FCGR2B and COVID-19: Notably, pre-incubation of complement-opsonized SARS-CoV-2 with COVID-19 convalescent serum abrogated type-I IFN and cytokine responses and responses were restored by blocking FcγRII (CD32) (Fig. 4A–G).